Call support free: +91-9555604444

NATDAC 60MG ( DACLATASVIR 60MG )

Description

Natdac 60mg ( Daclatasvir ) is an antiviral agent used as the active drug for the treatment of chronic hepatitis C first, second, third and fourth genotypes. Daclatasvir is suitable for people who are diagnosed with cirrhosis and compensated liver disease. The drug slows the progression of viral protein NS5A and further spread in the blood from infected cells. We Medimpex India exports Hepcinat 4000mg tablet to Russia, Kazakhstan, Kyrgyzstan, latvia, Poland, Belarus, Romania, Peru, Mexico, China, United states, United Kingdom, South Korea and many more countries.

Description

Natdac 60mg ( Daclatasvir ) is an antiviral agent used as the active drug for the treatment of chronic hepatitis C first, second, third and fourth genotypes. Daclatasvir is suitable for people who are diagnosed with cirrhosis and compensated liver disease. The drug slows the progression of viral protein NS5A and further spread in the blood from infected cells. We Medimpex India exports Hepcinat 4000mg tablet to Russia, Kazakhstan, Kyrgyzstan, latvia, Poland, Belarus, Romania, Peru, Mexico, China, United states, United Kingdom, South Korea and many more countries.

Pharmacological action

Daclatasvir is highly effective against all genotypes of hepatitis C virus (1,2,3,4). Daclatasvir Natdac has a shortened duration of therapy, independent of genotype, and easy portability of his patients, completes the security property. Pharmacological action is to suspend the development of HCV and its spread through the cells of the body. Daclatasvir should not be used as a single drug when in combination with other antiviral drugs. The effectiveness of the medication depends on its combination with other drugs on prescription.

Indications for use

Daclatasvir is used in the diagnosis of hepatitis C virus, in combination with other drugs, in particular with sofosbuvir (dose 400 mg).

Form release the Drug Daclatasvir Natdac is available in round orange tablets of 60 mg , 28 tablets in the package.

Part of Daclatasvir included accessories:

1) Croscarmellose sodium (disintegrant for quick dissolution of the tablet in the stomach).

2) magnesium Stearate (for the formation of a homogeneous mass the pills from all components).

3) silicon Dioxide. (used as an auxiliary component without affecting the body).

4) Cellulose (acts as a film-forming ingredient).

Method of application and doses

Daclatasvir Natdac it is recommended to use regularly, 1 time a day, with a dosage of 60 mg during food intake by swallowing whole with a small amount of water.

Taken within 3 months with sofosbuvir. The treatment takes place under medical supervision.

Side effects – Daclatasvir may cause side effects: dizziness, insomnia, dry skin, pain in joints and muscles, loss of appetite, headache, anemia, anxiety, stomach disorders, irritability, nausea, lower abdominal pain, constipation, and weakness. Side effects may be increased by the use of the drug with other drugs, the use of which is necessary to take them into account contraindications

Contraindications

use of Daclatasvir is not recommended:

1) In case of hypersensitivity and Allergy to any ingredient of the drug and lactose;

2) In pregnancy and breastfeeding of the child, which must cease for the duration of the treatment. It is recommended to use contraceptives for the woman and for her partner, in the course of treatment.

3) Persons under the age of 18.

4) For monotherapy.

During surgical procedures on the liver, transplantation and in the diagnosis of cirrhosis treatment is conducted under the supervision of a physician, taking into account possible risks.

Interaction with other drugs –  Daclatasvir  has the property of decreasing efficiency in the treatment with simultaneous use with drugs that produce the glycoprotein and cytochrome, which include: St. John’s wort, dexamethasone, carbamazepine, rifabutin, rifampicin, phenobarbital, oxcarbazepine.

Storage conditions – Natdac should be stored in a dry dark place at temperature 15-30⁰С, without children, with observance of the specified on the package expiration date.

Natdag Daclatasvir 60 mg (Daclatasvir) refers to the number of effective antiviral drugs that slow down the synthesis of proteins NS5A and used for the treatment of hepatitis C 1, 2, 3, and 4 genotype.

The drug is suitable for a broad range of patients (including those with cirrhosis of the liver) and has a number of advantages, including shortened course of therapy, the excellent portability, users, and minimal risk of side effects.

Acceptable price of this antiviral drug, manufactured in India, due to the fact that it is an exact analogue of drugs known American company Gilead Sciences. You can buy it without any additional cost and risk to fake from Medimpexindia.

 

Reviews

There are no reviews yet.

Be the first to review “NATDAC 60MG ( DACLATASVIR 60MG )”

WhatsApp chat